Highlight Capital — Full Portfolio
38 tracked investments · listed companies and verified rows first
T-CURX is a venture-backed biotechnology company developing autologous CAR-T cell therapies using proprietary non-viral technologies, including in vivo and bedside-manufactured CAR-T approaches based on T cell-targeted LNP delivery of Sleeping Beauty transposon vectors.
BiotechHealthtechWürzburg, DE
Michael Hudecek(Co-founder)Christoph Rader(Co-founder & Member of the Scientific Advisory Board)Ulf Grawunder(Co-founder & CEO)in
Co-investorsBioMedPartnersi&i Biotech Fund
Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.
BiotechDeep TechHealthtech
Co-investors5Y CapitalCoatue ManagementFuzhou Jiebao Rongan Venture CapitalQiming Venture PartnersSoftBank Vision FundBoyu Capital+7 more
Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition.
BiotechDigital HealthMedical DevicesSan Diego, US
Litain Yeh(Co-Founder & Chief Executive Officer)inShunqi Yan(Co-Founder & Chief Operating Officer)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)
BoardZhang Mingyuan(Director)
Co-investorsHM Venture PartnersMaxpro Ventures
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsFrazier Life SciencesMRL Ventures FundXeraya CapitalAmgen VenturesBlackRockBlackstone Life Sciences+5 more
MCT manufactures satellite positioning and GNSS evaluation kits for automotive and robotics applications, featuring tri-band RTK receivers with automotive-grade certifications for operation in extreme temperatures.
AI & Machine LearningDeep TechHardwareRoboticsSemiconductorsChangzhou, CN
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesSingapore, SG
Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in
Co-investorsAngelini VenturesKurma PartnersBoehringer Ingelheim Venture FundClavystBioSEEDS Capital
Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.
AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US
Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in
Co-investors20/20 HealthCare Partners LLCYonghua Capital
WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America.
Advanced ManufacturingBiotechEnterprise SoftwareHealthtech
Co-investorsHongShan Capital GroupHuangpu River CapitalVivo CapitalLegend Capital
Zentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
BiotechHealthtechMedical Devices
Julie Eastland(Chief Executive Officer and Director)in
BoardScott Myers(Chairperson)
Co-investorsDecheng Capital
Shanghai General Healthy Information & Technology develops intelligent medical logistics and automation equipment, including automated pharmacy dispensing systems marketed under the CONSIS and SANTO brands, for hospitals.
Digital HealthHardwareHealthtechRoboticsShanghai, CN
Pharmaron provides drug research and development services globally, supporting the discovery and development of pharmaceutical therapies through integrated capabilities across multiple geographic regions.
Advanced ManufacturingBiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesBeijing, CN
楼柏良(董事长兼首席执行官 (Chairman & CEO))Lou Bailiang(Chemist, Chairman & CEO)
Co-investorsLegend Capital
Zylox-Tonbridge Medical is a Chinese medical device company developing clinical solutions and products, with a focus on neurovascular and peripheral vascular interventional treatments.
HardwareHealthtechMedical DevicesHangzhou, CN
Smoore is an atomization technology company that develops and manufactures vaping and electronic atomization devices.
Advanced ManufacturingHardware
Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices.
BiotechDigital HealthHealthtechMedical DevicesHangzhou, CN
Co-investorsQiming Venture Partners
Chinese fabless semiconductor company developing enterprise-grade interconnect chips, including PCIe interface chips, memory interface chips and buffers, network interface chips, and clock/general interface chips.
Deep TechHardwareSemiconductorsChengdu, CN
Drug discovery services (01873.HK)
Medical imaging equipment company (688271.SH)
Jeffrey M Bundyin
Co-investorsDetong Capital
Medical device company (002223.SZ)
KK Chips designs automotive semiconductor solutions including power management, driver, and control chips for 12V and 24V automotive systems used in electric vehicles, hybrid vehicles, and commercial vehicles.
HardwareMobility & TransportationSemiconductorsGuangzhou, CN
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
GaushImago BioSciences, Inc.上海君屹亚电科技凯因科技剂泰科技千寻智能华夏英泰博瑞医药圣湘生物拓烯科技星能玄光百洋医药科美诊断科辉智药药明康德蓝色向量逻辑比特长江存储高视医疗
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



























